P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas

BACKGROUND: We investigated the immunohistochemical expression of p53, MAPK, topoisomerase II alpha (topoII alpha) and Ki67 in ovarian serous carcinomas (OSCs) along with mutational analysis for KRAS and BRAF. METHODS: Eighty one cases of OSCs were reviewed and examined immunohistochemically using a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sundov, Dinka, Caric, Ana, Mrklic, Ivana, Gugic, Dijana, Capkun, Vesna, Hofman, Irena Drmic, Mise, Branka Petric, Tomic, Snjezana
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570323/
https://ncbi.nlm.nih.gov/pubmed/23388101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-8-21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados